Sign up for our free China-Africa Week in Review email newsletter
  • This field is for validation purposes and should be left unchanged.

Follow CAP on Social Media

Listen to the CAP Podcast

Chile’s Reliance on Chinese-Made Vaccines Provides a Cautionary Example for Public Health Officials in Africa and Other Developing Regions

A health worker administers a dose of the Chinese CoronaVac vaccine against COVID-19 to a man at a vaccination center in Santiago, on March 30, 2021. Martin BERNETTI / AFP

A number of events have converged to further constrict the flow of COVID-19 vaccines to Africa and other regions throughout the Global South. India, once a major vaccine exporter, halted all overseas shipments in an effort to contain a massive surge of infections at home. In turn, that has put further pressure on the global Covax alliance, which has been struggling of late to find enough supply for the world’s poorest countries. And then, last week’s decision by Johnson & Johnson to temporarily take its vaccine off the market to concerns over blood clotting has made the situation even worse.

  • Get a daily email packed with the latest China-Africa news and analysis.
  • Read exclusive insights on the key trends shaping China-Africa relations.
  • Connect with leading professionals on the China- Africa Experts Network.

You’ve reached your free monthly article limit.

Subscribe today for unlimited access.

What is The China-Africa Project?

Independent

The CAP is passionately independent, non-partisan and does not advocate for any country, company or culture.

News

A carefully curated selection of the day’s most important China-Africa stories. Updated 24 hours a day by human editors. No bots, no algorithms.

Analysis

Diverse, often unconventional insights from scholars, analysts, journalist and a variety of stakeholders in the China-Africa discourse.

Networking

A unique professional network of China-Africa scholars, analysts, journalists and other practioners from around the world.